Amarin Corp Plc (AMRN)

[couldbebetter]

Babr, Appreciate your insights from experience. For me it confirms the
need for BP to...uhmm...takeover? sales operations. Some time ago there
was a retired Pfizer sales rep posting his view that if Pfizer owned
Vascepa they would have a 2 year marketing campaign with special
incentives for sales reps to get doctors to write scrips. Once a
doctor is sold on the effectiveness and need for Vascepa they will
continue to write scrips for all of their patients who they believe
would benefit. But it does no good if the doctor is not informed or
might have preconceived notions about a medication without having a
chance to know the facts. In Europe there is no direct to consumer
advertising so the sales rep has an even more critical function.
Vascepa will not sell itself. Vascepa needs an army of sales reps...
ideally those with already established relationships in the CV/Diabetes
specialties.